News

Gilead posts profit, says HIV prevention drug on track for mid-June
Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...
Gilead Sciences Announces First Quarter 2025 Financial Results
(Nasdaq: GILD) announced today its first quarter 2025 results of operations. "Gilead had a strong start to the year driven by ...
Gilead reports Q1 adjusted EPS $1.81, consensus $1.77
Reports Q1 reveue $6.7B, consensus $6.81B. “Gilead (GILD) had a strong start to the year driven by excellent commercial and clinical execution ...
From era-defining polemic to generic action thriller: How The Handmaid’s Tale lost its way
This visceral drama felt like the definitive show of the first Trump presidency. But, argues Fiona Sturges, the further it’s ...
‘The Handmaid’s Tale’ star Samira Wiley on Moira ‘ending her trauma in Gilead’
WARNING: The following story contains spoilers about the fifth episode of The Handmaid's Tale's sixth and final season, ...
Will 'The Handmaid's Tale' return for another season? A sequel is in the works
"The Handmaid's Tale" may be coming to an end, but the world of Gilead is not with a sequel, "The Testaments," in production ...
Gilead Sciences Stock Slips After Mixed Q1 Results, Lowered FY25 EPS Guidance
Gilead Sciences releases its first-quarter results after Thursday's closing bell. Here's a look at the details from the report.
Gilead reports quarterly profit, revenue flat as cancer sales slow
Gilead Sciences on Thursday reported slightly higher-than-expected quarterly earnings on flat revenue, as higher sales of ...